BXRX
Baudax Bio Inc
-52.79%
$3.41 - $1.61
Feb 7th 2023 - Mar 21st 2023
Mar, 7, 2023
Drop rates and decrease diesel cost and in 3 month... See more
Feb, 13, 2023
“We believe the use of BX1000, combined with our r... See more
TGTX
TG Therapeutics Inc
-19.05%
$18.43 - $14.92
Feb 7th 2023 - Mar 21st 2023
Feb, 4, 2023
It’s not just the efficacy and safety of the produ... See more
Dec, 30, 2022
The analyst comments "TGTX stock is up >15... See more
GME
GameStop Corp.
-16.82%
$21.22 - $17.65
Feb 7th 2023 - Mar 21st 2023
Mar, 21, 2023
$GME GameStop shares surge as cost cuts drive surp... See more
Mar, 21, 2023
The indicators on BBBY are overwhelmingly bullish,... See more
Mar, 7, 2023
Drop rates and decrease diesel cost and in 3 months inflation is gone.
Feb, 13, 2023
“We believe the use of BX1000, combined with our reversal agent, BX3000, could make for precise control of timing under neuromuscular paralysis for surgical patients, which could result in time and cost savings for patients and hospitals alike.
Dec, 17, 2022
This could be significantly impactful for patients, surgeons, and anesthesiologists by enhancing safety, and possibly saving time and reducing costs related to delayed recovery from neuromuscular paralysis following surgical procedures.”
Oct, 1, 2022
Amazing how little this costs and continues to drop.
Feb, 4, 2023
It’s not just the efficacy and safety of the product, it is the less cost for hospital/infusion, due to one hour infusion and the huge difference in price.
Dec, 30, 2022
The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,
Dec, 30, 2022
Each treatment cost under $10k per treatment.
Dec, 30, 2022
Each treatment cost under $10k per treatment.
Dec, 29, 2022
The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,
Mar, 21, 2023
$GME GameStop shares surge as cost cuts drive surprise profit https://newsfilter.io/a/3d33b0998d4bbfc887d6f24eea654ef2
Mar, 21, 2023
The indicators on BBBY are overwhelmingly bullish, the short interest is over 100%, the cost to borrow has been over 100% and climbing for a while, and lastly (most importantly) the fails to deliver are out of control.
Mar, 3, 2023
$SNDL WE BUY, WE EXPAND, WE TRIPLE REVENUE, WE REDUCE COSTS, WE LOAN CAPITAL, WE GROW WORLDWIDE, WE ARE DEBT FREE.
Jan, 11, 2023
Increasing cost to borrow, share prices rising, and the PR’s are undeniably positive.
Dec, 28, 2022
$GME iTs coSt noThin to hoLd!
Nov, 28, 2022
56% cost to borrow 4m market cap 15m float $7 52 week high‼️ ESP UP 110% More revenue then market cap Beautiful chart I am long this for the next JCSE ATXG GSUN $AMC $GME
Oct, 17, 2022
Cost savings are astronomical - you don’t have to chop limbs off of DM pts.
Oct, 11, 2022
HE HAS NEVER BEEN WRONG!!!! YOU KNOW ITS LEGIT BECAUSE HIS SERVICE COSTS $2000 A YEAR (NO REFUNDS UNLESS YOU HAVE A LAWYER)
Oct, 3, 2022
Still very short and also thank you for dramatically reducing the borrow cost of your paper handed Ape shares.